Position in GH
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$50,803
-$5,374 QoQ
Shares Held
550
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026HighMark Wealth Management LLC holds $6,490,037 across 9 Diagnostics & Research names. GH ranks #5 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NEO |
Neogenomics Inc
|
579,834 | $4,302,368 | |
| 2 | TWST |
Twist Bioscience Corp
|
39,290 | $1,867,060 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
199 | $111,816 | |
| 4 | DHR |
Danaher Corp /De/
|
560 | $106,176 | |
| 5 | GH |
Guardant Health, Inc.
This page
|
550 | $50,803 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
|
75 | $36,864 | |
| 7 | CDNA |
CareDx, Inc.
|
475 | $8,246 | |
| 8 | A |
Agilent Technologies, Inc.
|
58 | $6,610 |
All Filings in GH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $50,803 | 550 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $56,177 | 550 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $34,364 | 550 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $28,622 | 550 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $23,430 | 550 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $16,802 | 550 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $12,617 | 550 | Shares | Sole | 2024-10-17 | |
| No filing history on record for this holder in this stock. | ||||||